Meeting
2021 ASCO Annual Meeting
Post-transplant lymphoproliferative disorder in kidney transplant patients: A multicenter report.
Authors
Elise A. Chong
Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
Elise A. Chong , Daniel E. Tsai , Mitchell E. Hughes , Mary Ann C Lim , Behdad D. Besharatian , Yvonne El Kassiss , Roy Bloom , Deepa Jagadeesh
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Track
Hematologic Malignancies
Sub Track
Non-Hodgkin Lymphoma
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 7564)
DOI
10.1200/JCO.2021.39.15_suppl.7564
Abstract #
7564
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Incidence of large granular lymphocytosis (LGL) in patients with late cytopenias after allogeneic blood or marrow transplantation (AlloBMT).
First Author: Marcus Messmer
Poster
2020 ASCO Virtual Scientific Program
Assessing the effect of immunosuppressive agents for immune-related adverse event management on tumor response.
First Author: Pankti Reid
Poster
2013 ASCO Annual Meeting
Incidence of posttransplantation lymphoproliferative disorder (PTLD) following allogeneic blood or marrow transplantation (alloBMT) using post-transplantation cyclophosphamide (PT-Cy) for graft-versus-host disease (GVHD) prophylaxis.
First Author: Jennifer Ann Kanakry
Poster
2021 ASCO Annual Meeting
Early results of phase 1 study of JSP191, an anti-CD117 monoclonal antibody, with non-myeloablative conditioning in older adults with MRD-positive MDS/AML undergoing allogeneic hematopoietic cell transplantation.
First Author: Lori S. Muffly